Interestingly, certain immune gene sets such as “Lymphocyte Activation” and “Cell Activation Involved in Immune Response,” alongside immune pathways like the “IL-17 Signaling Pathway,” demonstrated enrichment in the TMSI-high group in GBM, PRAD, and OV. Here, IL17A is linked to prostate adenocarcinoma.